They have only just started their phase 3. It's only going to have around 128 patients. Let's see how long it takes to enroll. I can't even find it in clinical trials.gov yet.
Meanwhile, we are looking at the big picture, teaming up with Vanderbilt University and going after all cause ARDS. Sure, I wish it was started already, but I am happy we're heading there with a top notch investigator...
Interesting MSC's Article, page-8
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.3¢ |
Change
-0.013(1.30%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $1.344M | 1.405M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 385556 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 100908 | 58 |
View Market Depth
| Last trade - 15.00pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |